Cite
HARVARD Citation
Muller, Y. et al. (2018). Rituximab as monotherapy for the treatment of chronic active antibody‐mediated rejection after kidney transplantation. Transplant international. pp. 451-455. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Muller, Y. et al. (2018). Rituximab as monotherapy for the treatment of chronic active antibody‐mediated rejection after kidney transplantation. Transplant international. pp. 451-455. [Online].